Literature DB >> 23411363

[Infections caused by Clostridium difficile].

Dolors Rodríguez-Pardo1, Beatriz Mirelis, Ferran Navarro.   

Abstract

The epidemiology of Clostridium difficile infections (CDIs) has dramatically changed over the last decade in both North America and Europe, and it has become more frequent, more severe, more refractory to standard therapy, and more likely to relapse. These changes have been associated with the emergence of a "hypervirulent" strain known as BI/NAP1/027 which has become endemic in some areas, although, other hypervirulent genotypes (e.g. PCR ribotype 078) have also been described. To reduce the incidence of CDIs, the diagnostic guidelines on diagnosis and treatment methods have been recently updated. The aim of this review is to highlight the recent epidemiological data on CDIs and to provide an overview of the pathogenicity of the infection, diagnostic approaches, old and new treatment options, and current knowledge of infection control measures.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23411363     DOI: 10.1016/j.eimc.2012.12.010

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  3 in total

1.  The need for evolution in the management of febrile neutropenia in pediatric cancer: TRIIO KIDS update.

Authors:  Maria Luisa Navarro; Montserrat Nieto; Antonio Perez-Martínez
Journal:  Clin Transl Oncol       Date:  2022-10-16       Impact factor: 3.340

2.  Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain.

Authors:  Miguel Salavert; Javier Cobo; Álvaro Pascual; Belén Aragón; Stefano Maratia; Yiling Jiang; Susana Aceituno; Santiago Grau
Journal:  Adv Ther       Date:  2018-10-16       Impact factor: 3.845

3.  Significance of a polymerase chain reaction method in the detection of Clostridioides difficile.

Authors:  J Jaqueti Aroca; L M Molina Esteban; I García-Arata; J García-Martínez; I Cano De Torres; S Prieto Menchero
Journal:  Rev Esp Quimioter       Date:  2021-02-19       Impact factor: 1.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.